A "Tie-in" to MW
|Written by GSCR Staff|
|Wednesday, 26 June 2013 09:02|
A few months back we broke from ‘serious’ stock writing to put in our two cents on the Herbalife (NYSE – HLF) drama. Let’s face it, human conflict sells on TV and Wall Street as people love clashes and quarrels. Charts and numbers are no contests for spats and board room spectacle.
As you may or may not know, the board at The Men’s Wearhouse (NYSE – MW - $37.31) fired founder and Chairman George Zimmer last week after irreconcilable differences between him and his handpicked successor, CEO Doug Ewert. You may recognize Zimmer from the company’s TV ad tagline, “…You’re gonna like the way you look, I guarantee it.” There are several reasons that have been suggested to have been causes for the rift. Yesterday, it came to light that Mr. Zimmer wanted to take the company private and sell to a private investment group and was blocked by the board. Any way you cut it this was an ugly divorce but created some great entertainment over the last few days.
We believe this drama could enable the MW stock jump over the next few months. However, instead of buying the stock it may be time to buy some calls. The August 2013 calls for $40 and $41 strike are priced at $70 and $50 respectively. These may turn out to be cheap ways to get in on a big spike.
Here are the three reasons we think there is short term pop in the works:
First, one of the rumors that were swirling initially was that Zimmer and Ewert were clashing over the sale of the company’s low-end chain, K&G. The board and Ewert wanted to sell, Zimmer did not. With Zimmer out of the picture, this sale, and adding some quick cash is now a possibility.
The second item to consider here is that where there is smoke there is fire. Once the company brought in a 3rd party to consult on the sale, it opened the floodgates to the possibility of being bought in the future, privately or publicly. And we all know that being the acquired, is almost always good news for the stock.
Finally, upsetting a self-made billionaire, like Zimmer may come back to haunt the board at MW. He may decide to buy the company back just for spite. See above about the acquired.
Just as a quick check, technical analysis is very bullish to bullish for the short-term, intermediate, and long-term. This might be the opportune time to bet on the drama at MW with some options.
Have a great day.
Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.
This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports.
It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com
Leave your comments